{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02652351",
      "OrgStudyIdInfo": {
        "OrgStudyId": "HYK-hepatic cirrhosis"
      },
      "Organization": {
        "OrgFullName": "Shenzhen Hornetcorn Bio-technology Company, LTD",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis",
      "OfficialTitle": "Safety and Efficacy Study of Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis"
    },
    "StatusModule": {
      "StatusVerifiedDate": "January 2016",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "March 2016"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "May 2016",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "October 2016",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "January 7, 2016",
      "StudyFirstSubmitQCDate": "January 7, 2016",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "January 11, 2016",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "May 20, 2016",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "May 23, 2016",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Shenzhen Hornetcorn Bio-technology Company, LTD",
        "LeadSponsorClass": "INDUSTRY"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "The Second Affiliated Hospital of University of South China",
            "CollaboratorClass": "UNKNOWN"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of this study is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cell(hUC-MSC) for Hepatic Cirrhosis.",
      "DetailedDescription": "Human umbilical cord mesenchymal stem cells exhibit the potential to differentiate into mature cells typical of several tissues, which have been confirmed in in vivo and in vitro experiments. There have been few clinical reports describing umbilical cord mesenchymal stem cells for treatment of Hepatic Cirrhosis.\n\nTo investigate the effects of hUC-MSC treatment for Hepatic Cirrhosis, 20 patients with Hepatic Cirrhosis will be enrolled and receive 4 times of hUC-MSC transplantation."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Hepatic Cirrhosis"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Stem cell",
          "Human Umbilical Cord Mesenchymal Stem Cell",
          "Mesenchymal Stem Cell",
          "Hepatic Cirrhosis"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "20",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "hUC-MSC treatment",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Patients will receive human umbilical cord mesenchymal stem cells transplantation with a 12 months follow-up.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Human umbilical cord mesenchymal stem cells"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Human umbilical cord mesenchymal stem cells",
            "InterventionDescription": "A single dose of 2×107 hUC-MSC will be implanted to patients by intravenous infusion or Hepatic artery intervention, and repeated every week for four times.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "hUC-MSC treatment"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "hUC-MSC"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Severity of adverse events",
            "PrimaryOutcomeDescription": "According to National Cancer Institute Common Terminology Criteria for Adverse Events（NCI-CTCAE)",
            "PrimaryOutcomeTimeFrame": "12 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Hepatic function",
            "SecondaryOutcomeDescription": "Include AST, ALT, T-Bil and A/G.",
            "SecondaryOutcomeTimeFrame": "1, 3 ,6 and 12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Liver fibrosis index",
            "SecondaryOutcomeDescription": "The level of Hyaluronidase,Laminin,Procollagen Ⅲ and Collagen Type IV in serum.",
            "SecondaryOutcomeTimeFrame": "1, 3 ,6 and 12 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nThe patient who have signed the informed consent document;\nClinical, radiological, or biochemical evidence of liver cirrhosis.\n\nExclusion Criteria:\n\nPregnant women or lactating mothers;\nPatients who have received any anti-inflammatory drugs including herb-drug within 14 days;\nPatients who received any drug by intra-articular injection for treatment within 2 months prior to this enrollment;\nPatients with positive human immunodeficiency (HIV) at screening indicative of current of pass infection;\nAbnormal blood coagulation, combine other tumor or special condition;\nPatients who had participated in other clinical trials within three months prior to this study.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "80 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Jin S Cao, lab master",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+86 0734-53137955",
            "CentralContactEMail": "CaoJS@hornetcon.com"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Gang Chen, Professor",
            "OverallOfficialAffiliation": "The second Affiliated Hospital of University of Soth China",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "The second Affiliated Hospital of University of Soth China",
            "LocationStatus": "Recruiting",
            "LocationCity": "Hengyang",
            "LocationState": "Hunan",
            "LocationZip": "431224",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Gang Chen, Professor",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "0734-8899939",
                  "LocationContactPhoneExt": "621",
                  "LocationContactEMail": "Chengang@126.com"
                }
              ]
            }
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "Undecided"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000008103",
            "ConditionMeshTerm": "Liver Cirrhosis"
          },
          {
            "ConditionMeshId": "D000005355",
            "ConditionMeshTerm": "Fibrosis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000008107",
            "ConditionAncestorTerm": "Liver Diseases"
          },
          {
            "ConditionAncestorId": "D000004066",
            "ConditionAncestorTerm": "Digestive System Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M10255",
            "ConditionBrowseLeafName": "Liver Cirrhosis",
            "ConditionBrowseLeafAsFound": "Hepatic Cirrhosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M7637",
            "ConditionBrowseLeafName": "Fibrosis",
            "ConditionBrowseLeafAsFound": "Cirrhosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M10259",
            "ConditionBrowseLeafName": "Liver Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8035",
            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M6407",
            "ConditionBrowseLeafName": "Digestive System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC06",
            "ConditionBrowseBranchName": "Digestive System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}